Jican Liu

514 total citations
12 papers, 398 citations indexed

About

Jican Liu is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Jican Liu has authored 12 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Biomaterials and 3 papers in Oncology. Recurrent topics in Jican Liu's work include Nanoparticle-Based Drug Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Jican Liu is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Jican Liu collaborates with scholars based in China, South Korea and Hong Kong. Jican Liu's co-authors include Changyou Zhan, Juan Guan, Yang Yang, Zhuxuan Jiang, Weiyue Lu, Zui Zhang, Jun Qian, Cheng Li, Wei Hua and Ying Mao and has published in prestigious journals such as Nature Communications, Nano Letters and Advanced Healthcare Materials.

In The Last Decade

Jican Liu

12 papers receiving 394 citations

Peers

Jican Liu

BIOMA

IMMUN

ONCOL

Christina L. Parker United States

Zui Zhang China

Kristian Juul‐Madsen Denmark

Yixuan Tang China

Stefan M. Mladjenovic Canada

Marina Demoy France

Maya Juenet France

Si Cheng China

Emma McErlean United Kingdom

Christina L. Parker United States

Jican Liu

178 ×0.8

BIOMA

218 ×1.1

108 ×0.7

30 ×0.7

IMMUN

38 ×1.1

ONCOL

Citations per year, relative to Jican Liu Jican Liu (= 1×) peers Christina L. Parker

Countries citing papers authored by Jican Liu

Since Specialization

Citations

This map shows the geographic impact of Jican Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jican Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jican Liu more than expected).

Fields of papers citing papers by Jican Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jican Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jican Liu. The network helps show where Jican Liu may publish in the future.

Co-authorship network of co-authors of Jican Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jican Liu. A scholar is included among the top collaborators of Jican Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jican Liu. Jican Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dai, Li‐Yang, et al.. (2025). Integrating spatial transcriptomics and single-cell RNA-sequencing reveals epithelial cell alterations in benign prostatic hyperplasia following finasteride treatment. Genes & Diseases. 12(5). 101526–101526. 1 indexed citations

Liu, Jican, et al.. (2024). Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia. Journal of Translational Medicine. 22(1). 380–380. 8 indexed citations

Wang, Weixia, Yingyi Zhang, Jican Liu, et al.. (2023). Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer. World Journal of Surgical Oncology. 21(1). 31–31. 2 indexed citations

Liu, Jing, Kui Lu, Jican Liu, et al.. (2023). The predictive value of CD4, CD8, and C—reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer. BMC Gastroenterology. 23(1). 194–194. 1 indexed citations

Liu, Jican, et al.. (2022). CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. International Immunopharmacology. 106. 108598–108598. 11 indexed citations

Wang, Weixia, Jican Liu, Yingyi Zhang, et al.. (2021). Correlation between schistosomiasis and CD8+ T cell and stromal PD-L1 as well as the different prognostic role of CD8+ T cell and PD-L1 in schistosomal-associated colorectal cancer and non-schistosomal-associated colorectal cancer. World Journal of Surgical Oncology. 19(1). 321–321. 4 indexed citations

Yang, Yang, Kaiqi Long, Yiqun Wang, et al.. (2021). NIR Light‐Triggered Quantitative Pulsed Drug Release. Advanced Healthcare Materials. 11(8). e2102362–e2102362. 17 indexed citations

Jiang, Zhuxuan, Jican Liu, Juan Guan, et al.. (2021). Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines. Nano Letters. 21(11). 4744–4752. 20 indexed citations

Wang, Weixia, Kui Lu, Limei Wang, et al.. (2020). Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer. World Journal of Surgical Oncology. 18(1). 149–149. 11 indexed citations

10.

Zhang, Zui, Juan Guan, Zhuxuan Jiang, et al.. (2019). Brain-targeted drug delivery by manipulating protein corona functions. Nature Communications. 10(1). 3561–3561. 270 indexed citations

11.

Guan, Juan, Zhuxuan Jiang, Mengke Wang, et al.. (2019). Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility. Molecular Pharmaceutics. 16(2). 907–913. 26 indexed citations

12.

Guan, Juan, Zui Zhang, Xuefeng Hu, et al.. (2017). Cholera Toxin Subunit B Enabled Multifunctional Glioma‐Targeted Drug Delivery. Advanced Healthcare Materials. 6(23). 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact